Barriers to enrollment in a randomized controlled trial of hydrocortisone for cardiovascular insufficiency in term and late preterm newborn infants

OBJECTIVE: To analyze reasons for low enrollment in an RCT of the effect of hydrocortisone for cardiovascular insufficiency on survival without neurodevelopmental impairment (NDI) in term/late-preterm newborns. STUDY DESIGN: The original study was a multicenter RCT. Eligibility: ≥34 weeks’ gestation...

Descripción completa

Detalles Bibliográficos
Autores principales: Watterberg, Kristi L., Fernandez, Erika, Walsh, Michele C., Truog, William E., Stoll, Barbara J., Sokol, Gregory M., Kennedy, Kathleen A., Fraga, Maria V., Beauman, Sandra Sundquist, Carper, Benjamin, Das, Abhik, Duncan, Andrea Freeman, Buss, William F., Gauldin, Cheri, Lacy, Conra Backstrom, Sanchez, Pablo J., Chawla, Sanjay, Lakshminrusimha, Satyan, Cotten, C. Michael, Van Meurs, Krisa P., Poindexter, Brenda B., Bell, Edward F., Carlo, Waldemar A., Devaskar, Uday, Wyckoff, Myra H., Higgins, Rosemary D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688018/
https://www.ncbi.nlm.nih.gov/pubmed/28880260
http://dx.doi.org/10.1038/jp.2017.131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688018/
https://www.ncbi.nlm.nih.gov/pubmed/28880260
http://dx.doi.org/10.1038/jp.2017.131

Ejemplares similares